Elsayed E. Ibrahim
Embryonic NANOG activity defines colorectal cancer stem cells and modulates through AP1- and TCF-dependent mechanisms
Ibrahim, Elsayed E.; Babaei-Jadidi, Roya; Saadeddin, Anas; Spencer-Dene, Bradley; Hossaini, Sina; Abuzinadah, Mohammed; Li, Ningning; Fadhil, Wakkas; Ilyas, Mohammad; Bonnet, Dominique; Nateri, Abdolrahman S.
Authors
Dr ROYA BABAEI-JADIDI Roya.Babaei-jadidi@nottingham.ac.uk
RESEARCH FELLOW
Anas Saadeddin
Bradley Spencer-Dene
Sina Hossaini
Mohammed Abuzinadah
Ningning Li
Wakkas Fadhil
Mohammad Ilyas
Dominique Bonnet
Dr ABDOLRAHMAN SHAMS-NATERI a.nateri@nottingham.ac.uk
ASSOCIATE PROFESSOR
Abstract
Embryonic NANOG (NANOG1) is considered as an important regulator of pluripotency while NANOGP8 (NANOG-pseudogene) plays a role in tumorigenesis. Herein, we show NANOG is expressed from both NANOG1 and NANOGP8 in human colorectal cancers (CRC). Enforced NANOG1-expression increases clonogenic potential and tumor formation in xenograft models, although it is expressed only in a small subpopulation of tumor cells and is colocalized with endogenous nuclear β-cateninHigh. Moreover, single NANOG1-CRCs form spherical aggregates, similar to the embryoid body of embryonic stem cells (ESCs), and express higher levels of stem-like Wnt-associated target genes. Furthermore, we show that NANOG1-expression is positively regulated by c-JUN and β-catenin/TCF4. Ectopic expression of c-Jun in murine Apc Min/+-ESCs results in the development of larger xenograft tumors with higher cell density compared to controls. Chromatin immunoprecipitation assays demonstrate that c-JUN binds to the NANOG1-promoter via the octamer M1 DNA element. Collectively, our data suggest that β-Catenin/TCF4 and c-JUN together drive a subpopulation of CRC tumor cells that adopt a stem-like phenotype via the NANOG1-promoter. © AlphaMed Press.
Citation
Ibrahim, E. E., Babaei-Jadidi, R., Saadeddin, A., Spencer-Dene, B., Hossaini, S., Abuzinadah, M., Li, N., Fadhil, W., Ilyas, M., Bonnet, D., & Nateri, A. S. (2012). Embryonic NANOG activity defines colorectal cancer stem cells and modulates through AP1- and TCF-dependent mechanisms. STEM CELLS, 30(10), 2076-2087. https://doi.org/10.1002/stem.1182
Journal Article Type | Article |
---|---|
Online Publication Date | Sep 20, 2012 |
Publication Date | Oct 1, 2012 |
Deposit Date | Sep 11, 2024 |
Journal | Stem Cells |
Print ISSN | 1066-5099 |
Electronic ISSN | 1549-4918 |
Publisher | AlphaMed Press |
Peer Reviewed | Peer Reviewed |
Volume | 30 |
Issue | 10 |
Pages | 2076-2087 |
DOI | https://doi.org/10.1002/stem.1182 |
Keywords | NANOG1, β-Catenin, c-JUN, Cancer stem cell |
Public URL | https://nottingham-repository.worktribe.com/output/39457933 |
Publisher URL | https://academic.oup.com/stmcls/article/30/10/2076/6415775?login=true |
You might also like
Mast Cell Tryptase Release Contributes to Disease Progression in Lymphangioleiomyomatosis
(2021)
Journal Article
FLYWCH1, a Multi-Functional Zinc Finger Protein Contributes to the DNA Repair Pathway
(2021)
Journal Article